Enlivex Therapeutics Ltd.
ENLV | NASDAQ
$1.29
-$0.10 (-7.19%)
At close: Nov 5, 2026, 3:59 PM ET
$1.35
+$0.06 (+4.65%)
After-hours:
Nov 5, 2026, 5:16 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 2.01M | 3.3M | 813K | 49.95M | 11.2M | 5.67M |
Short-Term Investments | 3.86M | 20.2M | 26.51M | 299K | 72.93M | 30.03M |
Long-Term Investments | 374K | 531K | 308K | n/a | 3K | 89K |
Other Long-Term Assets | n/a | 10K | 179K | 412K | 482K | 8K |
Receivables | 235K | 1.3M | 229K | 647K | 1.09M | 1.24M |
Inventory | n/a | n/a | n/a | 1.18M | n/a | n/a |
Other Current Assets | 1.73B | 198K | 5.11M | -1.18M | 113K | -72K |
Total Current Assets | 1.74B | 25.99M | 33.76M | 52.33M | 86.44M | 38.12M |
Property-Plant & Equipment | 938K | 1.15M | 2.58M | 14.9M | 8.22M | 2.14M |
Goodwill & Intangibles | 582.51M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 583.82M | 1.69M | 3.07M | 15.31M | 8.7M | 2.24M |
Total Assets | 2.33B | 27.69M | 36.83M | 67.64M | 95.15M | 40.36M |
Account Payables | 3.81M | 811K | 827K | 1.95M | 878K | 463K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | 653K | n/a | n/a |
Other Current Liabilities | 1.89M | 142K | 1.57M | 2.71M | 1.07M | 1.17M |
Total Current Liabilities | 9.02M | 3.8M | 6.06M | 6.61M | 4.72M | 4.37M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 383.03M | 299K | 686K | 4.19M | 5.39M | 499K |
Total Liabilities | 392.05M | 4.1M | 6.75M | 10.8M | 10.11M | 4.87M |
Total Debt | 641K | 534K | 1.03M | 4.85M | 6.01M | 203K |
Book Value | 1.93B | 23.59M | 30.08M | 56.84M | 85.04M | 35.49M |
Book Value Per Share | 9.58K | 275.98 | 388.71 | 741.61 | 1.14K | 646.72 |
Common Stock | 28.73M | 2.69M | 2.14M | 2.12M | 2.11M | 1.65M |
Retained Earnings | 1.11B | -127.11M | -112.09M | -83.03M | -51.97M | -37.5M |
Comprehensive Income | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 977K |
Shareholders Equity | 1.93B | 23.59M | 30.08M | 56.84M | 85.04M | 35.49M |
Total Investments | 4.24M | 20.73M | 26.82M | 299K | 72.93M | 30.03M |
Add to Watchlist
Select watchlists to add or remove ENLV